GSK chief says RSV vaccine will start off slower than shingles shot – but will drive future salesCNBC • 07/26/23
Pharma Giant GSK Beats Second-Quarter Goals On Growth In Vaccines, General MedicinesInvestors Business Daily • 07/26/23
Lloyds, GSK, Reckitt and BAT results lead a busy Wednesday, plus Fed meetingProactive Investors • 07/25/23
GSK trading near year lows in run-up to results, questions remain for Dame EmmaProactive Investors • 07/21/23
GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella VaccineBusiness Wire • 07/20/23